CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Kino Biotech Co Ltd Company Snapshot
Kino Biotech Co Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Kino Biotech Co Ltd with three other pharmaceutical manufacturers in Asia: Twi Pharmaceuticals Inc of Taiwan (2015 sales of 437.37 million Taiwanese Dollars [US$14.40 million] of which 96% was Generic Drug), Bafna Pharmaceuticals Limited of India (976.75 million Indian Rupees [US$14.92 million] ), and Genovate Biotechnology Co., Limited which is based in Taiwan (477.60 million Taiwanese Dollars [US$15.73 million] of which 100% was Pharmaceutical Manufacturing).

Sales Analysis. During the year ended December of 2015, sales at Kino Biotech Co Ltd were 20.93 million Singapore Dollars (US$14.96 million). This is an increase of 11.3% versus 2014, when the company's sales were 18.80 million Singapore Dollars. Sales of Healthcare Patches saw an increase that was more than double the company's growth rate: sales were up 48.9% in 2015, from 991,343.10 Singapore Dollars to 1.48 million Singapore Dollars. Not all segments of Kino Biotech Co Ltd experienced an increase in sales in 2015: sales of Others fell 29.2% to 361,072.20 Singapore Dollars. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Kino Biotech Co Ltd
  Stock Performance Chart for Kino Biotech Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): .94
(Figures in Singapore Dollars)
1 Week 0.8%   13 Weeks -7.4%  
4 Weeks 4.3%   52 Weeks 2.2%  
 
Kino Biotech Co Ltd Key Data:
  Ticker: 4154 Country: Singapore
  Exchanges: TAI Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 20,929,408
(Year Ending Jan 2016).
Employees: 103
  Currency: Singapore Dollars Market Cap: 18,355,026
  Fiscal Yr Ends: December Shares Outstanding: 19,526,000
  Share Type: Ordinary Closely Held Shares: 14,184,000
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.